Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Tourmaline Bio (TRML) Earnings Date, Estimates & Call Transcripts

Tourmaline Bio logo

Tourmaline Bio Earnings Summary

Tourmaline Bio released Q2 2025 earnings on August 13, 2025, reporting an EPS of -$0.90, which beat the consensus estimate of -$0.94 by $0.04. With a trailing EPS of -$3.43, Tourmaline Bio's earnings are expected to decrease next year, from ($3.02) to ($3.56) per share.

Consensus EPS
(Aug. 13)
-$0.94
Actual EPS
(Aug. 13)
-$0.90 Beat By $0.04

Q2 2025 Earnings Resources

Get Tourmaline Bio Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Tourmaline Bio and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

TRML Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Tourmaline Bio Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20262-$1.10-$0.93-$1.02
Q2 20262-$1.21-$0.94-$1.08
Q3 20262-$1.09-$0.95-$1.02
Q4 20262-$1.23-$0.96-$1.10

Tourmaline Bio Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/13/2025Q2 2025-$0.94-$0.90+$0.04-$0.90--
5/2/2025Q1 2025-$0.91-$0.89+$0.02-$0.89--
3/13/2025Q4 2024-$0.91-$0.86+$0.05-$0.86-$0.04M
11/7/2024--$0.84-$0.78+$0.06-$0.78--
8/8/2024--$0.72-$0.68+$0.04-$0.68--
5/13/2024Q1 2024-$0.68-$0.55+$0.13-$0.55--

Data powered by Fiscal.ai.

Tourmaline Bio Earnings - Frequently Asked Questions

Tourmaline Bio (NASDAQ:TRML) last announced its quarterly earning data on Wednesday, August 13, 2025. Learn more on TRML's earnings history.

In the previous quarter, Tourmaline Bio (NASDAQ:TRML) reported ($0.90) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.94) by $0.04. Learn more on analysts' earnings estimate vs. TRML's actual earnings.

Tourmaline Bio's earnings report can be found in their filing with the SEC.
View SEC filing

Tourmaline Bio (NASDAQ:TRML) has a recorded net income of -$73.21 million. TRML has generated -$3.43 earnings per share over the last four quarters.

Tourmaline Bio's earnings are expected to decrease from ($3.02) per share to ($3.56) per share in the next year.


This page (NASDAQ:TRML) was last updated on 5/9/2026 by MarketBeat.com Staff.
From Our Partners